Cardiometabolic Health and Diabetes
FIDELIO DKD Results
Investigator Gerasimos Filippatos, MD summarizes the results of FIDELIO-DKD, which examined whether finerenone affected cardiovascular outcomes in patients with chronic kidney disease and T2DM.
American Heart Association Professional Members
Enjoy instant benefits!
- Free Online Access to AHA Scientific Journals
- Affiliate with our 16 Scientific Councils
- Discounts on Scientific Conference Registration and Online Courses